Skip to main content
SpringerLink
Log in

Molecular Genetic Diversity and DNA Diagnostics of Hereditary Spastic Paraplegia

  • Published:
Biology Bulletin Reviews Aims and scope Submit manuscript

Abstract—Hereditary spastic paraplegia (HSP) is a heterogeneous group of neurodegenerative disorders predominantly characterized by damage to the pyramidal tract. The major, single symptom of HSP is progressive weakness and spasticity of lower extremities, which ultimately leads to difficulties in walking. HSP has various types of inheritance and clinical characteristics. The development of molecular genetics and the emergence of high-throughput sequencing techniques, such as New Generation Sequencing (NGS) in particular, revealed a pronounced genetic heterogeneity of HSP. Currently, about 80 genetic loci for HSP are designated as spastic paraplegia genes (SPGs) (with numbering according to the mapping history), and the vast majority of causative genes within loci have been identified. The most frequent autosomal dominant forms of HSP are SPG4 and SPG3; SPG11, SPG15, SPG7 are common autosomal recessive HSPs. The mechanisms of HSP molecular pathogenesis are variable and encompassing defects of neuronal membrane transport and the disturbance of myelination processes, lipid metabolism, mitochondrial dysfunctions, etc. The differential diagnosis for HSPs is difficult due to the existence of many geno- and phenocopies within the other neuropathologies that can be partially distinguished by neuroimaging methods. The only method for the precise diagnostics of HSP and the number of genomic copies is DNA diagnostics—the search for mutations in individual genes and/or the analysis of many genes simultaneously by NGS methods (gene panel, whole-exome sequencing, and whole-genome sequencing). Such DNA diagnostics opens up the opportunity to perform prenatal or preimplantation analysis of the fetus for families carrying HSP mutations to predict the risk of HSP inheritance. Currently, HSP treatment is directed against individual symptoms (antispastic drugs, etc.), and the discovery of the pathogenic action of different genes requires the development of new therapeutic approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. Abdollahpour, H., Alawi, M., Kortum, F., et al., An AP4B1 frameshift mutation in siblings with intellectual disability and spastic tetraplegia further delineates the AP-4 deficiency syndrome, Eur. J. Hum. Genet., 2015, vol. 23, no. 2, pp. 256–259. https://doi.org/10.1038/ejhg.2014.73

    Article  CAS  PubMed  Google Scholar 

  2. Abou Jamra, R., Philippe, O., Raas-Rothschild, A., et al., Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature, Am. J. Hum. Genet., 2011, vol. 88, no. 6, pp. 788–795. https://doi.org/10.1016/j.ajhg.2011.04.019

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Akhmetgaleeva, A.F., Molecular-genetic study of spastic paraplegia in the Republic of Bashkortostan, Extended Abstract of Cand. Sci. (Biol.) Dissertation, Ufa: Inst. Biochem. Genet., Ufa Sci. Center, Russ. Acad. Sci., 2017.

  4. Almontashiri, N.A., Chen, H.H., Mailloux, R.J., et al., SPG7 variant escapes phosphorylation-regulated processing by AFG3L2, elevates mitochondrial ROS, and is associated with multiple clinical phenotypes, Cell Rep., 2014, vol. 7, no. 3, pp. 834–847. https://doi.org/10.1016/j.celrep.2014.03.051

    Article  CAS  PubMed  Google Scholar 

  5. Arnoldi, A., Crimella, C., Tenderini, E., et al., Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations, Clin. Genet., 2012, vol. 81, no. 2, pp. 150–157. https://doi.org/10.1111/j.1399-0004.2011.01624.x

    Article  CAS  PubMed  Google Scholar 

  6. Balicza, P., Grosz, Z., Gonzalez, M.A., et al., Genetic background of the hereditary spastic paraplegia phenotypes in Hungary—an analysis of 58 probands, J. Neurol. Sci., 2016, vol. 364, pp. 116–121. https://doi.org/10.1016/j.jns.2016.03.018

    Article  CAS  PubMed  Google Scholar 

  7. Bauer, P., Winner, B., Schule, R., et al., Identification of a heterozygous genomic deletion in the spatacsin gene in SPG11 patients using high-resolution comparative genomic hybridization, Neurogenetics, 2009, vol. 10, no. 1, pp. 43–48. https://doi.org/10.1007/s10048-008-0144-2

    Article  CAS  PubMed  Google Scholar 

  8. Blackstone, C., Cellular pathways of hereditary spastic paraplegia, Annu. Rev. Neurosci., 2012, vol. 35, pp. 25–47. https://doi.org/10.1146/annurev-neuro-062111-150400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Boukhris, A., Feki, I., Elleuch, N., et al., A new locus (SPG46) maps to 9p21.2-q21.12 in a Tunisian family with a complicated autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum, Neurogenetics, 2010, vol. 11, no. 4, pp. 441–448. https://doi.org/10.1007/s10048-010-0249-2

    Article  PubMed  Google Scholar 

  10. Bross, P., Naundrup, S., Hansen, J., et al., The Hsp60-(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo, J. Biol. Chem., 2008, vol. 283, no. 23, pp. 15694–15700. https://doi.org/10.1074/jbc.M800548200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Buermans, H.P. and den Dunnen, J.T., Next generation sequencing technology: advances and applications, Biochim. Biophys. Acta, Mol. Basis Dis., 2014, vol. 1842, no. 10, pp. 1932–1941. https://doi.org/10.1016/j.bbadis.2014.06.015

    Article  CAS  Google Scholar 

  12. Chrestian, N., Dupre, N., Gan-Or, Z., et al., Clinical and genetic study of hereditary spastic paraplegia in Canada, Neurol. Genet., 2017, vol. 3, no. 1, art. ID e122. https://doi.org/10.1212/NXG.0000000000000122

    Article  PubMed  Google Scholar 

  13. Crimella, C., Baschirotto, C., Arnoldi, A., et al., Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot–Marie–Tooth type 2, Clin. Genet., 2012, vol. 82, no. 2, pp. 157–164. https://doi.org/10.1111/j.1399-0004.2011.01717.x

    Article  CAS  PubMed  Google Scholar 

  14. de Souza, P.V., de Rezende Pinto, W.B., de Rezende Batistella, G.N., et al., Hereditary spastic paraplegia: clinical and genetic hallmarks, Cerebellum, 2017, vol. 16, no. 2, pp. 525–551. https://doi.org/10.1007/s12311-016-0803-z

    Article  PubMed  Google Scholar 

  15. Denora, P.S., Santorelli, F.M., and Bertini, E., Hereditary spastic paraplegias: one disease for many genes, and still counting, Handb. Clin. Neurol., 2013, vol. 113, pp. 1899–1912. https://doi.org/10.1016/B978-0-444-59565-2.00060-5

    Article  PubMed  Google Scholar 

  16. Ebbing, B., Mann, K., Starosta, A., et al., Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity, Hum. Mol. Genet., 2008, vol. 17, no. 9, pp. 1245–1252. https://doi.org/10.1093/hmg/ddn014

    Article  CAS  PubMed  Google Scholar 

  17. Elert-Dobkowska, E., Stepniak, I., Krysa, W., et al., Molecular spectrum of the SPAST, ATL1 and REEP1 gene mutations associated with the most common hereditary spastic paraplegias in a group of Polish patients, J. Neurol. Sci., 015, vol. 359, nos. 1–2, pp. 35–39. https://doi.org/10.1016/j.jns.2015.10.030

  18. Erichsen, A.K., Koht, J., Stray-Pedersen, A., et al., Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study, Brain, 2009, vol. 132, no. 6, pp. 1577–1588. https://doi.org/10.1093/brain/awp056

    Article  PubMed  Google Scholar 

  19. Ferreirinha, F., Quattrini, A., Pirozzi, M., et al., Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport, J. Clin. Invest., 2004, vol. 113, no. 2, pp. 231–242. https://doi.org/10.1172/JCI20138

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Fink, J.K., Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms, Acta Neuropathol., 2013, vol. 126, no. 3, pp. 307–328. https://doi.org/10.1007/s00401-013-1115-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Gan-Or, Z., Bouslam, N., Birouk, N., et al., Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia, Am. J. Hum. Genet., 2016, vol. 98, no. 5, pp. 1038–1046. https://doi.org/10.1016/j.ajhg.2016.04.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Garone, C., Tadesse, S., and Hirano, M., Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy, Brain, 2011, vol. 134, no. 11, pp. 3326–3332. https://doi.org/10.1093/brain/awr245

    Article  PubMed  PubMed Central  Google Scholar 

  23. Goizet, C., Boukhris, A., Maltete, D., et al., SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum, Neurology, 2009, vol. 73, no. 14, pp. 1111–1119. https://doi.org/10.1212/WNL.0b013e3181bacf59

    Article  CAS  PubMed  Google Scholar 

  24. Gruenenfelder, F.I., Thomson, G., Penderis, J., et al., Axonglial interaction in the CNS: what we have learned from mouse models of Pelizaeus–Merzbacher disease, J. Anat., 2011, vol. 219, no. 1, pp. 33–43. https://doi.org/10.1111/j.1469-7580.2011.01363.x

    Article  PubMed  PubMed Central  Google Scholar 

  25. Harding, A.E., Classification of the hereditary ataxias and paraplegias, Lancet, 1983, vol. 321, no. 8334, pp. 1151–1155.

    Article  Google Scholar 

  26. Hensiek, A., Kirker, S., and Reid, E., Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing, J. Neurol., 2015, vol. 262, no. 7, pp. 1601–1612. https://doi.org/10.1007/s00415-014-7598-y

    Article  CAS  PubMed  Google Scholar 

  27. HGMD. https://www.portal.biobase-international.com/ hgmd/pro/start.php.

  28. Hirst, J., Edgar, J.R., Esteves, T., et al., Loss of AP-5 results in accumulation of aberrant endolysosomes: defining a new type of lysosomal storage disease, Hum. Mol. Genet., 2015, vol. 24, no. 17, pp. 4984–4996. https://doi.org/10.1093/hmg/ddv220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Illarioshkin, S.N., Rudenskaya, G.E., Ivanova-Smolenskaya, I.A., et al., Nasledstvennye ataksii i paraplegii (Inherited Ataxia and Paraplegia), Moscow: MEDpress-inform, 2006, pp. 286–390.

  30. Ishiura, H., Takahashi, Y., Hayashi, T., et al., Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses, J. Hum. Genet., 2014, vol. 59, no. 3, pp. 163–172. https://doi.org/10.1038/jhg.2013.139

    Article  PubMed  Google Scholar 

  31. Kara, E., Tucci, A., Manzoni, C., et al., Genetic and phenotypic characterization of complex hereditary spastic paraplegia, Brain, 2016, vol. 139, no. 7, pp. 1904–1918. https://doi.org/10.1093/brain/aww111

    Article  PubMed  PubMed Central  Google Scholar 

  32. Klebe, S., Lossos, A., Azzedine, H., et al., KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations, Eur. J. Hum. Genet., 2012, vol. 20, no. 6, pp. 645–649. https://doi.org/10.1038/ejhg.2011.261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Klebe, S., Stevanin, G., and Depienne, C., Clinical and genetic heterogeneity in hereditary spastic paraplegias: from SPG1 to SPG72 and still counting, Rev. Neurol., 2015, vol. 171, nos. 6–7, pp. 505–530. https://doi.org/10.1016/j.neurol.2015.02.017

  34. Liu, Y.T., Laura, M., Hersheson, J., et al., Extended phenotypic spectrum of KIF5A mutations: from spastic paraplegia to axonal neuropathy, Neurology, 2014, vol. 83, no. 7, pp. 612–619. https://doi.org/10.1212/WNL.0000000000000691

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lo Giudice, T., Lombardi, F., Santorelli, F.M., et al., Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms, Exp. Neurol., 2014, vol. 261, pp. 518–539. https://doi.org/10.1016/j.expneurol.2014.06.011

    Article  CAS  PubMed  Google Scholar 

  36. Lopez, E., Casasnovas, C., Gimenez, J., et al., Characterization of Alu and recombination-associated motifs mediating a large homozygous SPG7 gene rearrangement causing hereditary spastic paraplegia, Neurogenetics, 2015, vol. 16, no. 2, pp. 97–105. https://doi.org/10.1007/s10048-014-0429-6

    Article  CAS  PubMed  Google Scholar 

  37. Lynch, D.S., Koutsis, G., Tucci, A., et al., Hereditary spastic paraplegia in Greece: characterization of a previously unexplored population using next-generation sequencing, Eur. J. Hum. Genet., 2016, vol. 24, no. 6, pp. 857–863. https://doi.org/10.1038/ejhg.2015.200

    Article  PubMed  Google Scholar 

  38. Magzhanov, R.V., Saifullina, E.V., Idrisova, R.F., et al., Epidemiology of hereditary spastic paraplegias in Bashkortostan Republic, Med. Genet., 2013, vol. 12, no. 7 (133), pp. 12–16.

  39. Montenegro, G., Rebelo, A.P., Connell, J., et al., Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12, J. Clin. Invest., 2012, vol. 122, no. 2, pp. 538–544. https://doi.org/10.1172/JCI60560

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Murphy, S., Gorman, G., Beetz, C., et al., Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence, Neurology, 2009, vol. 73, no. 5, pp. 378–384. https://doi.org/10.1212/WNL.0b013e3181b04c6c

    Article  CAS  PubMed  Google Scholar 

  41. Musacchio, T., Zaum, A.K., Uceyler, N., et al., ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia, J. Neurol., 2017, vol. 264, no. 1, pp. 11–20. https://doi.org/10.1007/s00415-016-8301-2

    Article  CAS  PubMed  Google Scholar 

  42. Noetzli, L., Sanz, P.G., Brodsky, G.L., et al., A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2, Gene, 2014, vol. 533, no. 1, pp. 447–450. https://doi.org/10.1016/j.gene.2013.09.076

    Article  CAS  PubMed  Google Scholar 

  43. Novarino, G., Fenstermaker, A.G., Zaki, M.S., et al., Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders, Science, 2014, vol. 343, no. 6170, pp. 506–511. https://www.ncbi.nlm.nih.gov/omim.https://doi.org/10.1126/science.1247363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. OMIM. https://www.ncbi.nlm.nih.gov/omim.

  45. Orlacchio, A., Montieri, P., Babalini, C., et al., Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation, J. Neurol., 2011, vol. 258, no. 7, pp. 1361–1363. https://doi.org/10.1007/s00415-011-5934-z

    Article  PubMed  Google Scholar 

  46. Reid, E., Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias, J. Med. Genet., 2003, vol. 40, no. 2, pp. 81–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Ribai, P., Depienne, C., Fedirko, E., et al., Mental deficiency in three families with SPG4 spastic paraplegia, Eur. J. Hum. Genet., 2008, vol. 16, no. 1, pp. 97–104. https://doi.org/10.1038/sj.ejhg.5201922

    Article  CAS  PubMed  Google Scholar 

  48. Richard, S., Lavie, J., Banneau, G., et al., Hereditary spastic paraplegia due to a novel mutation of the REEP1 gene: case report and literature review, Medicine (Baltimore), 2017, vol. 96, no. 3, art. ID e5911. https://doi.org/10.1097/MD.0000000000005911

  49. Rismanchi, N., Soderblom, C., Stadler, J., et al., Atlastin GTPases are required for Golgi apparatus and ER morphogenesis, Hum. Mol. Genet., 2008, vol. 17, no. 11, pp. 1591–1604. https://doi.org/10.1093/hmg/ddn046

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Rudenskaya, G.E., Sermyagina, I.G., Illarioshkin, S.N., et al., Inherited spastic paraplegia type 4 (SPG4): clinical and molecular genetic characteristics, Zh. Nevropatol. Psikhiatr. im. S.S. Korsakova, 2010, vol. 110, no. 6, pp. 12–19.

    Google Scholar 

  51. Rydning, S.L., Wedding, I.M., Koht, J., et al., A founder mutation p.H701P identified as a major cause of SPG7 in Norway, Eur. J. Neurol., 2016, vol. 23, no. 4, pp. 763–771. https://doi.org/10.1111/ene.12937

    Article  CAS  PubMed  Google Scholar 

  52. Ryzhkova, O.P., Kardymon, O.L., Prokhorchuk, E.B., et al., Guidelines for the interpretation of massive parallel sequencing variants, Med. Genet., 2017, vol. 16, no. 7, pp. 4–17.

    Google Scholar 

  53. Sanchez-Ferrero, E., Coto, E., Beetz, C., et al., SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V, Clin. Genet., 2013, vol. 83, no. 3, pp. 257–262. https://doi.org/10.1111/j.1399-0004.2012.01896.x

    Article  CAS  PubMed  Google Scholar 

  54. Schüle, R. and Schöls, L., Genetics of hereditary spastic paraplegias, Semin. Neurol., 2011, vol. 31, no. 5, pp. 484–493. https://doi.org/10.1055/s-0031-1299787

  55. Schüle, R., Schlipf, N., Synofzik, M., et al., Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia, J. Neurol., Neurosurg., Psychiatry, 2009, vol. 80, no. 12, pp. 1402–1404. https://doi.org/10.1136/jnnp.2008.167528

  56. Shaw, M., Yap, T.Y., Henden, L., et al., Identical by descent L1CAM mutation in two apparently unrelated families with intellectual disability without L1 syndrome, Eur. J. Med. Genet., 2015, vol. 58, nos. 6–7, pp. 364–368. https://doi.org/10.1016/j.ejmg.2015.04.004

  57. Silver, J.R. Familial spastic paraplegia with amyotrophy of the hands, J. Neurol., Neurosurg., Psychiatry, 1996, vol. 29, pp. 135–144.

    Article  Google Scholar 

  58. Solowska, J.M. and Baas, P.W., Hereditary spastic paraplegia SPG4: what is known and not known about the disease, Brain, 2015, vol. 138, no. 9, pp. 2471–2484. https://doi.org/10.1093/brain/awv178

    Article  PubMed  PubMed Central  Google Scholar 

  59. Stevanin, G., Azzedine, H., Denora, P., et al., Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration, Brain, 2008, vol. 131, no. 3, pp. 772–784. https://doi.org/10.1093/brain/awm293

    Article  PubMed  Google Scholar 

  60. Synofzik, M. and Schüle, R., Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways, Mov. Disord., 2017, vol. 32, no. 3, pp. 332–345. https://doi.org/10.1002/mds.26944

    Article  PubMed  PubMed Central  Google Scholar 

  61. Tesson, C., Koht, J., and Stevanin, G., Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology, Hum. Genet., 2015, vol. 134, no. 6, pp. 511–538. https://doi.org/10.1007/s00439-015-1536-7

    Article  PubMed  PubMed Central  Google Scholar 

  62. Windpassinger, C., Auer-Grumbach, M., Irobi, J., et al., Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome, Nat. Genet., 2004, vol. 36, no. 3, pp. 271–276. https://doi.org/10.1038/ng1313

    Article  CAS  PubMed  Google Scholar 

  63. Zhao, G.H. and Liu, X.M., Clinical features and genotype-phenotype correlation analysis in patients with ATL1 mutations: a literature reanalysis, Transl. Neurodegener., 2017, vol. 6, p. 9. https://doi.org/10.1186/s40035-017-0079-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Zhu, P.P., Patterson, A., Lavoie, B., et al., Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin, J. Biol. Chem., 2003, vol. 278, no. 49, pp. 49063–49071. https://doi.org/10.1074/jbc.M306702200

    Article  CAS  PubMed  Google Scholar 

  65. Zinchenko, R.A., El’chinova, G.I., Baryshnikova, N.V., Polyakov, A.V., and Ginter, E.K., Prevalences of hereditary diseases in different populations of Russia, Russ. J. Genet., 2007, vol. 43, no. 9, pp. 1038–1045.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center for Medical Genetics, 115478, Moscow, Russia

    V. A. Kadnikova, O. P. Ryzhkova, G. E. Rudenskaya & A. V. Polyakov

Authors
  1. V. A. Kadnikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. P. Ryzhkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. E. Rudenskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. V. Polyakov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. A. Kadnikova.

Additional information

Translated by M. Batrukova

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kadnikova, V.A., Ryzhkova, O.P., Rudenskaya, G.E. et al. Molecular Genetic Diversity and DNA Diagnostics of Hereditary Spastic Paraplegia. Biol Bull Rev 9, 145–156 (2019). https://doi.org/10.1134/S2079086419020063

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S2079086419020063

Search

Navigation